IDEXX LABORATORIES INC /DE Other Non-current Liabilities 2009-2026 | IDXX
Beta
What is IDEXX LABORATORIES INC /DE's current other non-current liabilities?
IDEXX LABORATORIES INC /DE (IDXX) annual other non-current liabilities for 2025 was $56.5M, a 27.48% increase from 2024. IDEXX LABORATORIES INC /DE other non-current liabilities for the quarter ending March 31, 2026 was $54.0M.
What was IDEXX LABORATORIES INC /DE's other non-current liabilities in 2024?
IDEXX LABORATORIES INC /DE annual other non-current liabilities for 2024 was $44.3M, a 32.33% decline from 2023.
What was IDEXX LABORATORIES INC /DE's other non-current liabilities in 2023?
IDEXX LABORATORIES INC /DE annual other non-current liabilities for 2023 was $65.5M, a 3.05% decline from 2022.
What is IDEXX LABORATORIES INC /DE's 5-year other non-current liabilities CAGR?
IDEXX LABORATORIES INC /DE other non-current liabilities grew at a compound annual growth rate (CAGR) of 7.97% from FY2020 to FY2025, going from $85.6M to $56.5M over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-8.0%
FY2020
$85.6M
→
FY2025
$56.5M
0910111213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $56.5M | +27.5% | 10-K |
| FY2024 | $44.3M | -32.3% | 10-K |
| FY2023 | $65.5M | -3.0% | 10-K |
| FY2022 | $67.6M | -4.7% | 10-K |
| FY2021 | $70.9M | -17.1% | 10-K |
| FY2020 | $85.6M | +5.5% | 10-K |
| FY2019 | $81.2M | -4.3% | 10-K |
| FY2018 | $84.8M | -11.4% | 10-K |
| FY2017 | $95.7M | +145.8% | 10-K |
| FY2016 | $38.9M | +35.7% | 10-K |
| FY2015 | $28.7M | -11.3% | 10-K |
| FY2014 | $32.4M | +3.7% | 10-K |
| FY2013 | $31.2M | +30.6% | 10-K |
| FY2012 | $23.9M | +34.8% | 10-K |
| FY2011 | $17.7M | +60.5% | 10-K |
| FY2010 | $11.0M | -2.0% | 10-K |
| FY2009 | $11.3M | - | 10-K |
Company: IDEXX LABORATORIES INC /DETicker: IDXXSector: OtherIndustry: In Vitro & In Vivo Diagnostic SubstancesView company profile →